M 251 1-(2-Deoxy-2-fluoro-ß-D-arabinofuranosyl)-5-iodouracil  | 
  |
| Click here for Typical Certificate of Analysis | |
| (FIAU; Fialuridine) | |
| 
     Delivered ≥ 97% pure with dated HPLC UV chromatogram  | 
  |
| Solid | 1 mg $260 | 
| Screw cap v-vial - shipped on dry ice | 5 mg $680 | 
| M.W. 372.09 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
    MG 138 1-(2-Deoxy-2-fluoro-ß-D-arabinofuranosyl)-5-iodouracil, [uracil-2-13C1,15N2]-  | 
  |
| (FIAU, [uracil-2-13C1,15N2]-; Fialuridine, [uracil-2-13C1,15N2]-) | |
| 
     MORpure™, Delivered ≥ 98% pure with dated HPLC UV chromatogram  | 
  |
| Solid | 1 mg $615 | 
| Screw cap v-vial - shipped on dry ice | 5 mg $1930 | 
| M.W. 375.07 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
    MC 2508 1-(2-Deoxy-2-fluoro-ß-D-arabinofuranosyl)-5-iodouracil, [uracil-14C(U)]-  | 
  |
| (FIAU, [uracil-14C(U)]-; Fialuridine, [uracil-14C(U)]-) | |
| 
     MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram  | 
  |
| Ethanol:water (1:1) solution, 100 µCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | 10 μCi (370 kBq) $1240 | 
| NextGen V-Vial - shipped on dry ice | 50 μCi (1.85 MBq) $3970 | 
| M.W. 372.09 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
    MC 251 1-(2-Deoxy-2-fluoro-ß-D-arabinofuranosyl)-5-iodouracil, [uracil-2-14C]- Click here for Typical Certificate of Analysis  | 
  |
| (FIAU, [uracil-2-14C]-; Fialuridine, [uracil-2-14C]-) | |
| 
     MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram  | 
  |
| Ethanol:water (1:1) solution, 100 µCi/ml | |
| > 45 mCi(1.665 GBq)/mmol | 50 µCi (1.85 MBq) $3970 | 
| NextGen V-Vial - shipped on dry ice | |
| M.W. 372.09 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |